A detailed history of Axs Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Axs Investments LLC holds 6,000 shares of NVO stock, worth $630,360. This represents 0.2% of its overall portfolio holdings.

Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$630,360
Previous $856,000 16.59%
% of portfolio
0.2%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $736,260 - $881,460
-6,000 Reduced 50.0%
6,000 $856,000
Q1 2024

Aug 16, 2024

BUY
$102.11 - $135.92 $612,660 - $815,519
6,000 Added 100.0%
12,000 $1.54 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $183,798 - $244,655
1,800 Added 17.65%
12,000 $1.54 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $895,356 - $1.08 Million
10,200 New
10,200 $1.06 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Axs Investments LLC Portfolio

Follow Axs Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axs Investments LLC with notifications on news.